Literature DB >> 2115349

Should asymptomatic patients be tested for Chlamydia trachomatis in general practice?

H Buhaug1, F E Skjeldestad, L E Halvorsen, A Dalen.   

Abstract

Routine testing for Chlamydia trachomatis during gynaecological examinations has been suggested as a preventive measure against pelvic inflammatory disease and other health risks associated with chlamydial genital infections. This study examined the cost and effectiveness of routine testing for C trachomatis in general practice. An epidemiological model was used to predict how routine testing and treatment of positive cases would affect the future number of cases of pelvic inflammatory disease, infertility and ectopic pregnancy in a general practice population. The cost of routine test and treatment, and savings resulting from prevented future morbidity, were also estimated. For the population under study, a routine test for chlamydial infections in asymptomatic 18-24 year old women during gynaecological examinations was found to be cost effective but this was not the case for older women. At least two years should elapse between repeated tests.

Entities:  

Mesh:

Year:  1990        PMID: 2115349      PMCID: PMC1371240     

Source DB:  PubMed          Journal:  Br J Gen Pract        ISSN: 0960-1643            Impact factor:   5.386


  17 in total

1.  Criteria for selective screening for Chlamydia trachomatis infection in women attending family planning clinics.

Authors:  H H Handsfield; L L Jasman; P L Roberts; V W Hanson; R L Kothenbeutel; W E Stamm
Journal:  JAMA       Date:  1986-04-04       Impact factor: 56.272

2.  [Chlamydia trachomatis. Screening of pregnant women].

Authors:  F E Skjeldestad; A Dalen; H Buhaug; L S Bakketeig
Journal:  Tidsskr Nor Laegeforen       Date:  1987-09-10

3.  [Chlamydia commonly present in the teenage girls consulting the family planning clinics].

Authors:  V A Rahm; H Gnarpe; G Rosén
Journal:  Lakartidningen       Date:  1986-02-19

4.  The economic cost of pelvic inflammatory disease.

Authors:  A E Washington; P S Arno; M A Brooks
Journal:  JAMA       Date:  1986-04-04       Impact factor: 56.272

5.  Chlamydial cervicitis: a research study from general practice.

Authors:  H Fox
Journal:  J R Coll Gen Pract       Date:  1983-11

Review 6.  Epidemiology of sexually transmitted Chlamydia trachomatis infections.

Authors:  S E Thompson; A E Washington
Journal:  Epidemiol Rev       Date:  1983       Impact factor: 6.222

7.  Screening for chlamydial infections in women attending family planning clinics.

Authors:  J Schachter; E Stoner; J Moncada
Journal:  West J Med       Date:  1983-03

8.  Should tests for Chlamydia trachomatis cervical infection be done during routine gynecologic visits? An analysis of the costs of alternative strategies.

Authors:  R S Phillips; M D Aronson; W C Taylor; C Safran
Journal:  Ann Intern Med       Date:  1987-08       Impact factor: 25.391

9.  Cost-effectiveness of screening women at moderate risk for genital infections caused by Chlamydia trachomatis.

Authors:  M D Nettleman; R B Jones
Journal:  JAMA       Date:  1988-07-08       Impact factor: 56.272

10.  Pelvic inflammatory disease: etiologic studies with emphasis on chlamydial infection.

Authors:  H Gjønnaess; K Dalaker; G Anestad; P A Mårdh; G Kvile; T Bergan
Journal:  Obstet Gynecol       Date:  1982-05       Impact factor: 7.661

View more
  11 in total

Review 1.  Cost effectiveness of screening for Chlamydia trachomatis: a review of published studies.

Authors:  E Honey; C Augood; A Templeton; I Russell; J Paavonen; P-A Mårdh; A Stary; B Stray-Pedersen
Journal:  Sex Transm Infect       Date:  2002-12       Impact factor: 3.519

Review 2.  One to one interventions to reduce sexually transmitted infections and under the age of 18 conceptions: a systematic review of the economic evaluations.

Authors:  L Barham; D Lewis; N Latimer
Journal:  Sex Transm Infect       Date:  2007-07-11       Impact factor: 3.519

Review 3.  Screening for Chlamydia trachomatis: a systematic review of the economic evaluations and modelling.

Authors:  T E Roberts; S Robinson; P Barton; S Bryan; N Low
Journal:  Sex Transm Infect       Date:  2006-06       Impact factor: 3.519

4.  Cost effectiveness analysis of a population based screening programme for asymptomatic Chlamydia trachomatis infections in women by means of home obtained urine specimens.

Authors:  I G van Valkengoed; M J Postma; S A Morré; A J van den Brule; C J Meijer; L M Bouter; A J Boeke
Journal:  Sex Transm Infect       Date:  2001-08       Impact factor: 3.519

Review 5.  Drug therapies for sexually transmitted diseases. Clinical and economic considerations.

Authors:  W R Bowie
Journal:  Drugs       Date:  1995-04       Impact factor: 9.546

6.  Comparison of performance and cost-effectiveness of direct fluorescent-antibody, ligase chain reaction, and PCR assays for verification of chlamydial enzyme immunoassay results for populations with a low to moderate prevalence of Chlamydia trachomatis infection.

Authors:  D Dean; D Ferrero; M McCarthy
Journal:  J Clin Microbiol       Date:  1998-01       Impact factor: 5.948

Review 7.  Chlamydia trachomatis in adolescents and adults. Clinical and economic implications.

Authors:  C A Marra; D M Patrick; R Reynolds; F Marra
Journal:  Pharmacoeconomics       Date:  1998-02       Impact factor: 4.981

Review 8.  General practice update: chlamydia infection in women.

Authors:  P Oakeshott; P Hay
Journal:  Br J Gen Pract       Date:  1995-11       Impact factor: 5.386

9.  Optimizing strategies for population-based chlamydia infection screening among young women: an age-structured system dynamics approach.

Authors:  Yu Teng; Nan Kong; Wanzhu Tu
Journal:  BMC Public Health       Date:  2015-07-11       Impact factor: 3.295

Review 10.  How robust are the natural history parameters used in chlamydia transmission dynamic models? A systematic review.

Authors:  Bethan Davies; Sarah-Jane Anderson; Katy M E Turner; Helen Ward
Journal:  Theor Biol Med Model       Date:  2014-01-30       Impact factor: 2.432

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.